+1 347 708 0418
The Cancer Biotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cancer Biotherapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Cancer Biotherapy market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Cancer Biotherapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibodies
Vaccines
Erythropoietin
Colony Stimulating Factors
Interleukins and Interferons
Market segment by Application, can be divided into
Hospitals
Diagnostic Laboratories
Research and Academic Laboratories
Pharmaceutical and Biotechnology Companies
Others
Market segment by players, this report covers
Amgen
Bristol-Myers Squibb
Celgene
GlaxoSmithKline
Eli Lilly
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Cancer Biotherapy
1.2 Classification of Cancer Biotherapy by Type
1.2.1 Overview: Global Cancer Biotherapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Cancer Biotherapy Revenue Market Share by Type in 2020
1.2.3 Monoclonal Antibodies
1.2.4 Vaccines
1.2.5 Erythropoietin
1.2.6 Colony Stimulating Factors
1.2.7 Interleukins and Interferons
1.3 Global Cancer Biotherapy Market by Application
1.3.1 Overview: Global Cancer Biotherapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research and Academic Laboratories
1.3.5 Pharmaceutical and Biotechnology Companies
1.3.6 Others
1.4 Global Cancer Biotherapy Market Size & Forecast
1.5 Global Cancer Biotherapy Market Size and Forecast by Region
1.5.1 Global Cancer Biotherapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Cancer Biotherapy Market Size by Region, (2016-2021)
1.5.3 North America Cancer Biotherapy Market Size and Prospect (2016-2026)
1.5.4 Europe Cancer Biotherapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Cancer Biotherapy Market Size and Prospect (2016-2026)
1.5.6 South America Cancer Biotherapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Cancer Biotherapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Biotherapy Market Drivers
1.6.2 Cancer Biotherapy Market Restraints
1.6.3 Cancer Biotherapy Trends Analysis
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Cancer Biotherapy Product and Solutions
2.1.4 Amgen Cancer Biotherapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Amgen Recent Developments and Future Plans
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business
2.2.3 Bristol-Myers Squibb Cancer Biotherapy Product and Solutions
2.2.4 Bristol-Myers Squibb Cancer Biotherapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.3 Celgene
2.3.1 Celgene Details
2.3.2 Celgene Major Business
2.3.3 Celgene Cancer Biotherapy Product and Solutions
2.3.4 Celgene Cancer Biotherapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Celgene Recent Developments and Future Plans
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Cancer Biotherapy Product and Solutions
2.4.4 GlaxoSmithKline Cancer Biotherapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 GlaxoSmithKline Recent Developments and Future Plans
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly Cancer Biotherapy Product and Solutions
2.5.4 Eli Lilly Cancer Biotherapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Eli Lilly Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cancer Biotherapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Cancer Biotherapy Players Market Share
3.2.2 Top 10 Cancer Biotherapy Players Market Share
3.2.3 Market Competition Trend
3.3 Cancer Biotherapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cancer Biotherapy Revenue and Market Share by Type (2016-2021)
4.2 Global Cancer Biotherapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Cancer Biotherapy Revenue Market Share by Application (2016-2021)
5.2 Cancer Biotherapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Cancer Biotherapy Revenue by Type (2016-2026)
6.2 North America Cancer Biotherapy Revenue by Application (2016-2026)
6.3 North America Cancer Biotherapy Market Size by Country
6.3.1 North America Cancer Biotherapy Revenue by Country (2016-2026)
6.3.2 United States Cancer Biotherapy Market Size and Forecast (2016-2026)
6.3.3 Canada Cancer Biotherapy Market Size and Forecast (2016-2026)
6.3.4 Mexico Cancer Biotherapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Cancer Biotherapy Revenue by Type (2016-2026)
7.2 Europe Cancer Biotherapy Revenue by Application (2016-2026)
7.3 Europe Cancer Biotherapy Market Size by Country
7.3.1 Europe Cancer Biotherapy Revenue by Country (2016-2026)
7.3.2 Germany Cancer Biotherapy Market Size and Forecast (2016-2026)
7.3.3 France Cancer Biotherapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Cancer Biotherapy Market Size and Forecast (2016-2026)
7.3.5 Russia Cancer Biotherapy Market Size and Forecast (2016-2026)
7.3.6 Italy Cancer Biotherapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cancer Biotherapy Revenue by Type (2016-2026)
8.2 Asia-Pacific Cancer Biotherapy Revenue by Application (2016-2026)
8.3 Asia-Pacific Cancer Biotherapy Market Size by Region
8.3.1 Asia-Pacific Cancer Biotherapy Revenue by Region (2016-2026)
8.3.2 China Cancer Biotherapy Market Size and Forecast (2016-2026)
8.3.3 Japan Cancer Biotherapy Market Size and Forecast (2016-2026)
8.3.4 South Korea Cancer Biotherapy Market Size and Forecast (2016-2026)
8.3.5 India Cancer Biotherapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Cancer Biotherapy Market Size and Forecast (2016-2026)
8.3.7 Australia Cancer Biotherapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Cancer Biotherapy Revenue by Type (2016-2026)
9.2 South America Cancer Biotherapy Revenue by Application (2016-2026)
9.3 South America Cancer Biotherapy Market Size by Country
9.3.1 South America Cancer Biotherapy Revenue by Country (2016-2026)
9.3.2 Brazil Cancer Biotherapy Market Size and Forecast (2016-2026)
9.3.3 Argentina Cancer Biotherapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cancer Biotherapy Revenue by Type (2016-2026)
10.2 Middle East & Africa Cancer Biotherapy Revenue by Application (2016-2026)
10.3 Middle East & Africa Cancer Biotherapy Market Size by Country
10.3.1 Middle East & Africa Cancer Biotherapy Revenue by Country (2016-2026)
10.3.2 Turkey Cancer Biotherapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Cancer Biotherapy Market Size and Forecast (2016-2026)
10.3.4 UAE Cancer Biotherapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Cancer Biotherapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Cancer Biotherapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Cancer Biotherapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Cancer Biotherapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Cancer Biotherapy Revenue Market Share by Region (2021-2026)
Table 6. Amgen Corporate Information, Head Office, and Major Competitors
Table 7. Amgen Major Business
Table 8. Amgen Cancer Biotherapy Product and Solutions
Table 9. Amgen Cancer Biotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 11. Bristol-Myers Squibb Major Business
Table 12. Bristol-Myers Squibb Cancer Biotherapy Product and Solutions
Table 13. Bristol-Myers Squibb Cancer Biotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Celgene Corporate Information, Head Office, and Major Competitors
Table 15. Celgene Major Business
Table 16. Celgene Cancer Biotherapy Product and Solutions
Table 17. Celgene Cancer Biotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 19. GlaxoSmithKline Major Business
Table 20. GlaxoSmithKline Cancer Biotherapy Product and Solutions
Table 21. GlaxoSmithKline Cancer Biotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 23. Eli Lilly Major Business
Table 24. Eli Lilly Cancer Biotherapy Product and Solutions
Table 25. Eli Lilly Cancer Biotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Cancer Biotherapy Revenue (USD Million) by Players (2019-2021)
Table 27. Global Cancer Biotherapy Revenue Share by Players (2019-2021)
Table 28. Breakdown of Cancer Biotherapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Cancer Biotherapy Players Head Office, Products and Services Provided
Table 30. Cancer Biotherapy Mergers & Acquisitions in the Past Five Years
Table 31. Cancer Biotherapy New Entrants and Expansion Plans
Table 32. Global Cancer Biotherapy Revenue (USD Million) by Type (2016-2021)
Table 33. Global Cancer Biotherapy Revenue Share by Type (2016-2021)
Table 34. Global Cancer Biotherapy Revenue Forecast by Type (2021-2026)
Table 35. Global Cancer Biotherapy Revenue by Application (2016-2021)
Table 36. Global Cancer Biotherapy Revenue Forecast by Application (2021-2026)
Table 37. North America Cancer Biotherapy Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Cancer Biotherapy Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Cancer Biotherapy Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Cancer Biotherapy Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Cancer Biotherapy Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Cancer Biotherapy Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Cancer Biotherapy Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Cancer Biotherapy Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Cancer Biotherapy Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Cancer Biotherapy Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Cancer Biotherapy Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Cancer Biotherapy Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Cancer Biotherapy Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Cancer Biotherapy Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Cancer Biotherapy Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Cancer Biotherapy Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Cancer Biotherapy Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Cancer Biotherapy Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Cancer Biotherapy Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Cancer Biotherapy Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Cancer Biotherapy Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Cancer Biotherapy Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Cancer Biotherapy Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Cancer Biotherapy Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Cancer Biotherapy Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Cancer Biotherapy Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Cancer Biotherapy Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Cancer Biotherapy Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Cancer Biotherapy Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Cancer Biotherapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Cancer Biotherapy Picture
Figure 2. Global Cancer Biotherapy Revenue Market Share by Type in 2020
Figure 3. Monoclonal Antibodies
Figure 4. Vaccines
Figure 5. Erythropoietin
Figure 6. Colony Stimulating Factors
Figure 7. Interleukins and Interferons
Figure 8. Cancer Biotherapy Revenue Market Share by Application in 2020
Figure 9. Hospitals Picture
Figure 10. Diagnostic Laboratories Picture
Figure 11. Research and Academic Laboratories Picture
Figure 12. Pharmaceutical and Biotechnology Companies Picture
Figure 13. Others Picture
Figure 14. Global Cancer Biotherapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global Cancer Biotherapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global Cancer Biotherapy Revenue Market Share by Region (2016-2026)
Figure 17. Global Cancer Biotherapy Revenue Market Share by Region in 2020
Figure 18. North America Cancer Biotherapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe Cancer Biotherapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific Cancer Biotherapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America Cancer Biotherapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Middle East and Africa Cancer Biotherapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Cancer Biotherapy Market Drivers
Figure 24. Cancer Biotherapy Market Restraints
Figure 25. Cancer Biotherapy Market Trends
Figure 26. Amgen Recent Developments and Future Plans
Figure 27. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 28. Celgene Recent Developments and Future Plans
Figure 29. GlaxoSmithKline Recent Developments and Future Plans
Figure 30. Eli Lilly Recent Developments and Future Plans
Figure 31. Global Cancer Biotherapy Revenue Share by Players in 2020
Figure 32. Cancer Biotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Cancer Biotherapy Revenue Market Share in 2020
Figure 34. Global Top 10 Players Cancer Biotherapy Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Cancer Biotherapy Revenue Share by Type in 2020
Figure 37. Global Cancer Biotherapy Market Share Forecast by Type (2021-2026)
Figure 38. Global Cancer Biotherapy Revenue Share by Application in 2020
Figure 39. Global Cancer Biotherapy Market Share Forecast by Application (2021-2026)
Figure 40. North America Cancer Biotherapy Sales Market Share by Type (2016-2026)
Figure 41. North America Cancer Biotherapy Sales Market Share by Application (2016-2026)
Figure 42. North America Cancer Biotherapy Revenue Market Share by Country (2016-2026)
Figure 43. United States Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Cancer Biotherapy Sales Market Share by Type (2016-2026)
Figure 47. Europe Cancer Biotherapy Sales Market Share by Application (2016-2026)
Figure 48. Europe Cancer Biotherapy Revenue Market Share by Country (2016-2026)
Figure 49. Germany Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Cancer Biotherapy Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Cancer Biotherapy Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Cancer Biotherapy Revenue Market Share by Region (2016-2026)
Figure 57. China Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Cancer Biotherapy Sales Market Share by Type (2016-2026)
Figure 64. South America Cancer Biotherapy Sales Market Share by Application (2016-2026)
Figure 65. South America Cancer Biotherapy Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Cancer Biotherapy Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Cancer Biotherapy Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Cancer Biotherapy Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Cancer Biotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source
Buy
